This startup develops magnetic nanotechnology for radiation-free cancer diagnosis, focusing on applications such as staging, screening, and imaging. By eliminating the need for radioactivity and harsh chemicals, the technology enables healthcare providers to offer precise and less invasive treatment options for cancer patients.
Funding
$400K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional cancer diagnosis methods often rely on radiation and harsh chemicals, posing risks to patients and limiting the accessibility of frequent screenings. Current methods may also lack the precision needed for early detection and accurate staging of tumors.
Solution
SIAMAF Healthcare is developing magnetic nanotechnology solutions for radiation-free cancer theranostics, offering alternatives for cancer staging, screening, localization, imaging, and hyperthermia. Their technology utilizes magnetic nanoparticles to target and interact with cancer cells, enabling precise diagnostics and therapies without the harmful side effects of radiation. The company's product pipeline includes devices for early cancer detection from a single drop of blood, precise tumor localization, and targeted removal of harmful substances from the bloodstream. By eliminating the need for radioactivity and harsh chemicals, SIAMAF aims to provide healthcare providers with more precise, less invasive, and affordable treatment options.
Target Audience
The primary target audience includes oncologists, hospitals, and diagnostic centers seeking radiation-free and precise cancer diagnostic and therapeutic solutions.
Features
- **MafPro:** A handheld magnetic probe system for staging and localization of breast, head & neck, and colorectal cancer, eliminating the need for wires and nuclear medicine.
- **MafCyto:** A magnetic blood filtration system for removing cytokines, toxins, pathogens, and cells from a patient’s bloodstream using magnetic nanoparticle-based filtration.
- **MafTherm:** A magnetic hyperthermia system that uses FDA-approved magnetic nanoparticles and an alternating magnetic field to destroy cancer cells without radiation.
- **MafScreen:** A cancer screening system that diagnoses various cancer types from a single drop of blood using microfluidics, magnetic nanotechnology, high-speed camera technology, and AI.